Skip NavigationSkip to Content

Etiology, clinical characteristics, and risk factors associated with severe influenza-like illnesses in Mexican adults

  1. Author:
    Guerra-de-Blas, Paola Del Carmen
    Ortega-Villa, Ana M
    Ortiz-Hernández, Ana A
    Ramírez-Venegas, Alejandra
    Moreno-Espinosa, Sarbelio
    Llamosas-Gallardo, Beatriz
    Pérez-Patrigeon, Santiago
    Hunsberger, Sally
    Magaña, Martín
    Valdez-Vázquez, Rafael
    Freimanis, Laura
    Galán-Herrera, Juan Francisco
    Guerrero-Almeida, M Lourdes
    Powers,John
    Ruiz-Palacios, Guillermo M
    Beigel, John
    Galindo-Fraga, Arturo
  2. Author Address

    The Mexican Emerging Infectious Diseases Clinical Research Network (LaRed), Mexico City, Mexico. 2National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, USA. 3Instituto Nacional de Pediatría, Mexico City, Mexico. 4Instituto Nacional de Enfermedades Respiratorias "Ismael Cosío Villegas", Mexico City, Mexico. 5Hospital Infantil de México Federico Gómez, Instituto Nacional de Salud, Mexico City, Mexico. 6Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico. 7Hospital Regional Dr. Ignacio Morones Prieto, San Luis Potosí, Mexico. 8Hospital General "Dr. Manuel Gea González", Mexico City, Mexico. 9Westat, Rockville, Maryland, USA. 10Instituto Politécnico Nacional, Mexico City, Mexico. 11Clinical Research Directorate, Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA.
    1. Year: 2023
    2. Date: Mar
    3. Epub Date: 2023 02 01
  1. Journal: IJID Regions
    1. 6
    2. Pages: 152-158
  2. Type of Article: Article
  1. Abstract:

    The aim of this study was to determine the risk factors associated with severe influenza-like illness (ILI) in Mexican adults that could be useful to clinicians when assessing patients with ILI. Data from adult patients enrolled from 2010 through 2014 in ILI002 - a prospective hospital-based observational cohort study - were analyzed. Etiology and clinical characteristics were compared between cases of severe ILI (defined as hospitalization and/or death) and cases of non-severe ILI. Overall, 1428 (39.0%) out of a total 3664 cases of ILI were classified as severe. Adjusted analyses showed a higher risk of severe ILI associated with signs and symptoms related to lower tract infection, i.e. cough with sputum (odds ratio (OR) 2.037, 95% confidence interval (CI) 1.206-3.477; P = 0.008), dyspnea (OR 5.044, 95% CI 2.99-8.631; and shortness of breath (OR 5.24, 95% CI 3.0839.124; P < 0.001), and with increases in lactate dehydrogenase (OR 4.426, 95% CI 2.321-8.881; P < 0.001) and C-reactive protein (OR 3.618, 95% CI 2.5955.196; P < 0.001). Further, there was an increased risk of severe ILI with a longer time between symptom onset and inclusion (OR 1.108, 95% CI 1.049-1.172; P < 0.001) and with chronic steroid use (OR 14.324, 95% CI 8.059-26.216; P < 0.001). Respiratory viruses can cause severe ILI. The results of this study highlight the importance of evaluating data compatible with lower tract involvement and previous use of immunosuppressants at baseline, because patients meeting these conditions may develop severe illness. © 2023 The Authors.

    See More

External Sources

  1. DOI: 10.1016/j.ijregi.2023.01.012
  2. PMID: 36865993
  3. PMCID: PMC9972394
  4. PII : S2772-7076(23)00012-7

Library Notes

  1. Fiscal Year: FY2022-2023
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel